Elicio Therapeutics Inc
(ELTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,821 | 12,518 | 13,616 | 16,512 | 21,682 |
| TOTAL | $6,689 | $14,130 | $16,348 | $19,931 | $26,225 |
| Non-Current Assets | |||||
| PPE Net | 597 | 635 | 717 | 772 | 919 |
| Other Non-Current Assets | 8,464 | 9,715 | 10,081 | 10,284 | 10,475 |
| TOTAL | $9,061 | $10,350 | $10,798 | $11,056 | $11,394 |
| Total Assets | $15,750 | $24,480 | $27,146 | $30,987 | $37,619 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,055 | 1,105 | 4,369 | 4,406 | 4,265 |
| Accrued Expenses | 5,321 | 3,324 | 3,757 | 4,416 | 2,315 |
| Other current liabilities | 355 | 641 | 719 | 1,726 | 32 |
| TOTAL | $7,585 | $5,951 | $9,755 | $11,486 | $7,597 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 9,817 | 13,659 | 6,018 | 6,215 | 6,465 |
| TOTAL | $9,817 | $13,659 | $6,018 | $6,215 | $6,465 |
| Total Liabilities | $17,402 | $19,610 | $15,773 | $17,701 | $14,062 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,775 | 10,270 | 10,235 | 8,407 | 8,388 |
| Common Shares | 103 | 102 | 96 | 84 | 84 |
| Retained earnings | -161,259 | -154,030 | -142,203 | -133,254 | -122,596 |
| Other shareholders' equity | -388 | -420 | -347 | -175 | -152 |
| TOTAL | $-1,652 | $4,870 | $11,373 | $13,286 | $23,557 |
| Total Liabilities And Equity | $15,750 | $24,480 | $27,146 | $30,987 | $37,619 |